Driehaus Capital Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-79,242
Closed -$9.17M 484
2023
Q3
$9.17M Sell
79,242
-85,292
-52% -$9.16M 0.12% 219
2023
Q2
$16.9M Hold
164,534
0.21% 154
2023
Q1
$18M Buy
+164,534
New +$18.2M 0.25% 134
2022
Q3
Sell
-82,150
Closed -$6.55M 432
2022
Q2
$6.55M Buy
82,150
+2,563
+3% +$243K 0.11% 248
2022
Q1
$8.37M Sell
79,587
-21,438
-21% -$2.09M 0.1% 255
2021
Q4
$10.9M Buy
101,025
+40,875
+68% +$4.46M 0.11% 230
2021
Q3
$6.59M Buy
+60,150
New +$6.24M 0.08% 289
2020
Q4
Sell
-7,035
Closed -$546K 505
2020
Q3
$546K Buy
7,035
+2,804
+66% +$193K 0.01% 325
2020
Q2
$235K Sell
4,231
-26,069
-86% -$1.12M 0.01% 356
2020
Q1
$897K Sell
30,300
-47,400
-61% -$1.6M 0.03% 270
2019
Q4
$2.81M Sell
77,700
-17,200
-18% -$527K 0.07% 245
2019
Q3
$2.58M Buy
+94,900
New +$2.45M 0.08% 223
2019
Q2
Sell
-31,300
Closed -$827K 575
2019
Q1
$827K Buy
+31,300
New +$742K 0.03% 292
2016
Q1
Sell
-41,258
Closed -$894K 678
2015
Q4
$894K Buy
+41,258
New +$803K 0.03% 390
2015
Q3
Sell
-87,965
Closed -$3.06M 663
2015
Q2
$3.06M Sell
87,965
-35,418
-29% -$1.08M 0.11% 257
2015
Q1
$3.2M Buy
123,383
+49,586
+67% +$909K 0.11% 234
2014
Q4
$951K Sell
73,797
-9,815
-12% -$123K 0.04% 397
2014
Q3
$1.03M Sell
83,612
-580,230
-87% -$6.74M 0.04% 427
2014
Q2
$10.5M Buy
663,842
+587,330
+768% +$8.38M 0.34% 62
2014
Q1
$1.16M Buy
76,512
+52,655
+221% +$595K 0.04% 384
2013
Q4
$182K Buy
+23,857
New +$129K 0.01% 453

Other funds holding HZNP

Driehaus Capital Management's HZNP Position: Q4 2023 in Review

Driehaus Capital Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 79,242 shares — an estimated $9.17M sold.

Driehaus Capital Management first reported a position in HZNP in Q4 2013 and held it in 21 quarters. The position peaked at $18M in Q1 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Driehaus Capital Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Driehaus Capital Management sold 79,242 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $9.17M.
  • Driehaus Capital Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2013 and held it in 21 quarters.
  • Driehaus Capital Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $18M in Q1 2023.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Driehaus Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.